Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Feb 12, 2016 $54.33 $55.18 $51.05 $54.77 731 600
Feb 11, 2016 $51.48 $54.44 $50.01 $53.44 515 400
Feb 10, 2016 $52.19 $56.98 $50.36 $53.24 1 073 600
Feb 09, 2016 $49.70 $54.63 $49.00 $51.64 1 211 200
Feb 08, 2016 $52.28 $53.85 $49.23 $50.72 882 000
Feb 05, 2016 $54.15 $56.16 $53.11 $53.85 662 200
Feb 04, 2016 $57.89 $59.34 $52.02 $54.26 1 255 400
Feb 03, 2016 $60.96 $61.11 $51.52 $58.46 1 167 500
Feb 02, 2016 $60.81 $63.25 $59.42 $60.78 1 118 100
Feb 01, 2016 $56.57 $62.33 $54.86 $62.01 957 400
Jan 29, 2016 $60.82 $63.78 $54.00 $56.15 1 540 200
Jan 28, 2016 $65.88 $66.71 $58.47 $61.07 993 200
Jan 27, 2016 $73.65 $75.21 $64.17 $64.83 1 199 200
Jan 26, 2016 $77.36 $78.41 $70.00 $73.67 592 600
Jan 25, 2016 $75.18 $80.38 $74.69 $76.89 567 200
Jan 22, 2016 $76.86 $77.90 $73.37 $75.39 477 300
Jan 21, 2016 $78.96 $82.94 $73.53 $74.71 566 700
Jan 20, 2016 $70.05 $78.57 $65.75 $77.96 770 900
Jan 19, 2016 $81.16 $82.62 $69.26 $71.52 666 800
Jan 15, 2016 $78.13 $80.83 $76.29 $79.63 696 100
Jan 14, 2016 $78.17 $82.39 $70.49 $82.30 666 300
Jan 13, 2016 $87.32 $88.85 $75.55 $76.82 898 100
Jan 12, 2016 $82.85 $92.16 $79.47 $86.51 954 800
Jan 11, 2016 $87.16 $87.64 $76.88 $80.15 718 400
Jan 08, 2016 $93.14 $94.40 $86.20 $86.44 499 000
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT